糖化血红蛋白A1c和2型糖尿病社区医院中HbA1c用于诊断2型糖尿病的可靠性并不受慢性肾脏病的影响

Haemoglobin A 1 c and type 2 diabetes HbA1 c is a reliable test for type 2 diabetes in primary care irrespective of chronic kidney disease

原文传递

导出

摘要慢性肾脏病十分常见，并且有报道称它会影响糖化血红蛋白（HbA1c）的检测1,2。Kilpartick和Atkins反对在终末期肾病（CKD5期）中使用HbA1c来诊断2型糖尿病3，其观点与先前的报道一致4。但是，却没有证据表明HbA1c在慢性肾脏病更早的分期中的情况。

作者余洁许岭翎

机构地区北京协和医院内分泌科

出处《英国医学杂志中文版》 2015年第6期359-359,共1页 The BMJ Chinese Edition

关键词糖化血红蛋白 2型糖尿病肾脏病测试慢性保健患者

参考文献5

1NHS Information Centre. Health Survey for England-2009. Health and lifestyles. 2009. http ://data. gov. uk/dataset/health_survey_for england_2009 health_and_lifestyles.
2WHO. Use of glycated haemoglobin (HbAlc) in the diagnosis of diabetes mellitus. WHO/NMH/CHP/CPM/ll. 1 Geneva, World Health Organization, 2011.
3Kilpatrick ES, Atkins SL. Using haemoglobin A1 c to diagnose type 2 diabetes or to identify people at high risk of diabetes. BMJ 2014; 348 : g2867. (25 April. ).
4Ng JM, Cooke M, Bhandari S, Atkin SL, Kilpatrick ES. The effect of iron erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease. Diabetes Care 2010;33:2310-3.
5Shipman KE, Jawad M, Sullivan KM, Ford C, Gama R. Effect of chronic kidney disease on ale in individuals being screened for diabetes. Prim Care Diab 2014 ; published online 9 Feb.

英国医学杂志中文版

2015年第6期

内容加载中请稍等...